Determination of bisphosphonate drugs in pharmaceutical dosage formulations by ion chromatography with indirect UV detection
- 1 August 1994
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 12 (8) , 983-991
- https://doi.org/10.1016/0731-7085(94)00047-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Determination of etidronate disodium tablets by ion chromatography with indirect UV detectionJournal of Pharmaceutical and Biomedical Analysis, 1993
- Determination of disodium clodronate in bulk material and pharmaceuticals by ion chromatography with post-column derivatizationJournal of Pharmaceutical and Biomedical Analysis, 1992
- Determination of alendronate in pharmaceutical dosage formulations by ion chromatography with conductivity detectionJournal of Chromatography A, 1992
- The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1989
- Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Liquid chromatographic separation of phosphorus oxo acids and other anions with post-column indirect fluorescence detection by aluminum-morinAnalytical Chemistry, 1988
- Gas chromatographic analysis of Didronel tabletsJournal of Chromatography A, 1987
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- Clinical and biological effects of low doses of (3 amino‐1 hydroxypropylidene)‐1,1‐bisphosphonate (APD) in Paget's disease of boneEuropean Journal of Clinical Investigation, 1982